Paradoxic hypotension during dobutamine stress echocardiography: clinical and diagnostic implications
PA Marcovitz,
DS Bach,
W Mathias,
V Shayna,
and
WF Armstrong
Department of Internal Medicine, University of Michigan School of Medicine, Ann Arbor.
OBJECTIVES. The purpose of this study was to elucidate the prevalence, magnitude and clinical implications of a hypotensive response during dobutamine stress echocardiography. BACKGROUND. Dobutamine stress echocardiography is an accurate noninvasive method for detecting coronary artery disease. It has been associated with unexpected hypotension in a proportion of patients. Hypotension occurring during exercise testing has been associated with an increased prevalence of multivessel coronary artery disease and a poor prognosis. The clinical significance of hypotension when seen during dobutamine infusion for diagnostic testing is unknown. METHODS. Clinical characteristics, coronary artery anatomy (n = 41), ventricular function at rest and during dobutamine infusion and prognosis were evaluated in 115 patients experiencing hypotension during dobutamine stress echocardiography and compared with data in 59 nonhypotensive catheterized patients for comparison of coronary anatomy and in 239 nonhypotensive patients for prognostic purposes. RESULTS. Hypotension occurred in 115 (20%) of 568 consecutive patients studied with dobutamine stress echocardiography. It was gradual in 73 and precipitous in 42 patients. There were no statistical differences among the hypotensive groups and the index group in prevalence or severity of coronary disease or in prognosis during 15 months compared with findings in nonhypotensive patients. CONCLUSIONS. Hypotension occurs commonly during dobutamine stress echocardiography, and patients with dobutamine-induced hypotension constitute a heterogeneous group. Unlike hypotension occurring with exercise testing, dopamine-induced hypotension is not invariably associated with advanced coronary disease or an adverse prognosis.
This article has been cited by other articles:

|
 |

|
 |
 
J M Tsutsui, F C. Lario, D R Fernandes, I Kowatsch, J C Sbano, J A Franchini Ramires, and W Mathias Jr
Safety and cardiac chronotropic responsiveness to the early injection of atropine during dobutamine stress echocardiography in the elderly
Heart,
December 1, 2005;
91(12):
1563 - 1567.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Ueda, K. Mizushige, K. Yukiiri, K. Watanabe, and M. Kohno
Hypotension and Functional Left Ventricular Obstruction During Dobutamine Stress Echocardiography: Two Case Reports
Angiology,
July 1, 2001;
52(7):
489 - 492.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
M. L. Geleijnse, A. Elhendy, P. M. Fioretti, and J. R. T. C. Roelandt
Dobutamine stress myocardial perfusion imaging
J. Am. Coll. Cardiol.,
December 1, 2000;
36(7):
2017 - 2027.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Elhendy, R. T. van Domburg, J. J. Bax, R. Valkema, A. E. M. Reijs, E. P. Krenning, and J. R. T. C. Roelandt
Safety, Hemodynamic Profile, and Feasibility of Dobutamine Stress Technetium Myocardial Perfusion Single-Photon Emission CT Imaging for Evaluation of Coronary Artery Disease in the Elderly
Chest,
March 1, 2000;
117(3):
649 - 656.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. F. Lewis, L. Lin, S. McGorray, C. J. Pepine, M. Doyle, D. Edmundowicz, R. Holubkov, G. Pohost, N. Reichek, W. Rogers, et al.
Dobutamine stress echocardiography in women with chest pain: Pilot phase data from the National Heart, Lung and Blood Institute Women's Ischemia Syndrome Evaluation (WISE)
J. Am. Coll. Cardiol.,
May 1, 1999;
33(6):
1462 - 1468.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Luria, M.W. Klutstein, D. Rosenmann, J. Shaheen, S. Sergey, and D. Tzivoni
Prevalence and significance of left ventricular outflow gradient during dobutamine echocardiography
Eur. Heart J.,
March 1, 1999;
20(5):
386 - 392.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Elhendy, R. T. van Domburg, J. R. T. C. Roelandt, M. L. Geleijnse, M. M. Ibrahim, and P. M. Fioretti
Safety and Feasibility of Dobutamine-Atropine Stress Testing in Hypertensive Patients
Hypertension,
June 1, 1997;
29(6):
1232 - 1239.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. A. Panza, R. V. Curiel, J. M. Laurienzo, A. A. Quyyumi, and V. Dilsizian
Relation Between Ischemic Threshold Measured During Dobutamine Stress Echocardiography and Known Indices of Poor Prognosis in Patients With Coronary Artery Disease
Circulation,
October 15, 1995;
92(8):
2095 - 2101.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. A. Panza, V. Dilsizian, J. M. Laurienzo, R. V. Curiel, and P. T. Katsiyiannis
Relation Between Thallium Uptake and Contractile Response to Dobutamine : Implications Regarding Myocardial Viability in Patients With Chronic Coronary Artery Disease and Left Ventricular Dysfunction
Circulation,
February 15, 1995;
91(4):
990 - 998.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
E. C. Madu, W. Ahmar, J. Arthur, and T. D. Fraker Jr
Clinical Utility of Digital Dobutamine Stress Echocardiography in the Noninvasive Evaluation of Coronary Artery Disease
Arch Intern Med,
May 23, 1994;
154(10):
1065 - 1072.
[Abstract]
[PDF]
|
 |
|
|